HLTH 2022's Respiratory Disease Management Module Will Help Clinicians Make Better Treatment Decisions

By CIOReview | Saturday, December 24, 2022

The digital module for respiratory disease management is modernized to make digital therapeutic seamless for healthcare providers.

FREMONT, CA: The digital therapeutics space is growing as healthcare continues to modernize, and our team is working hard to make digital therapeutics seamless for healthcare providers and the patients they serve, said Manny Montalvo, SVP, Head of Digital Health & Innovation at Teva Pharmaceuticals. We're excited to integrate with Rimidi and leverage our innovative technologies to further our mission of improving patients' lives.

The release of Rimidi's new Respiratory Module, one of the leading clinical management platforms that optimize workflows, enhances patient experiences, and enables quality objectives, has revealed a complete picture of the treatment decisions for respiratory diseases to guide patients.

This new module incorporates pulse oximeter data into healthcare provider workflows and, through a new collaboration with Teva Pharma, digital inhalers into population health management, improving respiratory care.

Given that chronic respiratory conditions like asthma and COPD share many similarities with the cardiometabolic conditions that Rimidi already supports, such as the burden of daily home self-management and complex treatment guidelines, launching respiratory as our newest disease module made sense, said Lucienne Ide, MD, PhD, Founder, and CEO of Rimidi. Digital therapeutics, like the Digihaler platform, are making new data available to clinicians in managing complex diseases. We are thrilled to bring that data into the clinical workflow as part of our platform.

Millions of people suffer from respiratory disease, asthma, and chronic obstructive pulmonary disease. In many cases, patients with these conditions will lead to more expenses. With the company's full suite of disease modules, providers can encompass the full picture of the patient's disease status at the clinic and home. This empowers staff to make it personalize and improve the outcome.